TrialsgrambetaRCTs are beautiful

Simonetto AI-ECG (cirrhosis)

2026

Detection of Undiagnosed Liver Cirrhosis via AI-Enabled Electrocardiogram: a Pragmatic, Cluster-Randomized Clinical Trial

In 15,596 adults having a routine ECG in primary care, an AI-ECG alert for advanced chronic liver disease increased new diagnoses of chronic liver disease with advanced fibrosis within 180 days compared with usual care.

Result

Efficacy: New diagnosis of chronic liver disease with advanced fibrosis within 180 days of the ECGOR 2.09 (95% CI 1.22-3.55) · P = 0.007

Below 1 favours usual care, above 1 favours an AI-ECG alert for advanced chronic liver disease.

Event rates
Absolute difference
0.5 points
NNT
200

Absolute difference and NNT are derived from the event rates.

Also reported: Among ECG-ML-positive patients 4.4% vs 1.1% (OR 4.37, 95% CI 1.94–9.88; P<0.001); any fibrosis (secondary) 1.7% vs 0.5% (OR 3.17, 95% CI 1.86–5.40; P<0.001).

Original publication
Subtopic
Implementation & new uses
Design
Pragmatic cluster RCT (98 primary care teams)
Relevance
Important: one of several pillars.
Source
Simonetto DA, et al. Nat Med. 2026;32(1):160-167.doi 10.1038/s41591-025-04058-y

Discussion & critique

Extends the EAGLE design beyond the heart: a routine ECG becomes a case-finding test for a non-cardiac disease, with targeted liver testing downstream. The diagnostic yield stayed well below epidemiological estimates of advanced CLD prevalence, which the authors attribute to variable clinician adherence to the AI recommendation, the same adoption bottleneck seen in EAGLE and Rushlow. Diagnosis, not liver outcomes, was the endpoint; open-label cluster design.